Related by context. All words. (Click for frequent words.) 69 colorectal lung 69 ovarian lung 68 ovarian breast 67 prostate breast 67 pancreatic lung 66 lung colon 66 pancreatic prostate 66 cervical breast 66 lung prostate 66 ovarian colon 66 bladder cancers 66 pancreatic bladder 65 breast ovary 64 prostate pancreatic 64 lung colorectal 64 rectal cancers 64 pancreatic colorectal 64 metastatic colorectal 63 ovarian pancreatic 63 pancreatic gastric 63 breast uterine 63 lung pancreatic 63 breast pancreatic 63 colon breast 63 pancreatic colon 63 testicular cancers 63 esophagus colon 63 breast colorectal 63 colorectal prostate 63 cervical ovarian 63 colorectal ovarian 62 esophageal cancers 62 pancreatic ovarian 62 colon pancreas 62 ductal carcinomas 62 endometrial cancers 62 lung ovary 62 skeletal metastases 62 bladder prostate 62 basal cell carcinoma squamous 61 bladder colon 61 Basal cell 61 dysplastic lesions caused 61 endometrial ovarian 61 prostate colon 61 liver colon rectal 61 prostate ovarian 61 uterine ovarian 61 breast endometrial 61 Chronic myeloid leukemia CML 61 carcinoma HCC 61 cancers 61 nonmelanoma skin cancers 61 Papillary 61 hormone refractory prostate 61 Squamous cell 61 Colorectal cancer CRC 60 epithelial ovarian 60 unresectable tumors 60 breast ovarian 60 colon esophageal 60 bladder ovarian 60 colorectum 60 Endometrial cancer 60 colorectal breast 60 ovarian cervical 60 tongue mouth pharynx 60 ovarian prostate 60 colon prostate 60 precursor lesions 60 colon lung 60 ovarian colorectal 60 colorectal pancreatic 60 pancreas colon 60 squamous cell cancers 60 undergone radical prostatectomy 60 Uterine cancer 60 penile cancers 60 metastatic HER2 positive 60 cervix colon 60 uterine cervix 60 esophagus pancreas 60 gastric cancers 60 gastrointestinal cancers 60 deCODE BreastCancer 59 hormone receptor negative 59 ovarian endometrial 59 Gastric cancer 59 kidney urologic 59 breast colon 59 bladder cervix 59 situ CIS 59 metastatic prostate 59 gastrointestinal stromal 59 prostate bladder 59 colon pancreatic 59 pancreas esophagus 59 colon rectum breast 59 colorectal cancers 59 basal cell carcinoma BCC 59 CYT# potent vascular disrupting 59 cervix uteri 59 ovary uterus 59 osteosarcomas 59 Carcinoid tumors 59 squamous cell carcinomas 59 Androgen deprivation therapy 59 invasive lobular 58 oligodendrogliomas 58 endometrial hyperplasia 58 metachronous 58 renal cell carcinomas 58 prostate colorectal 58 invasive ductal 58 ductal breast cancer 58 leiomyomas 58 lobular carcinoma 58 nonsmall cell lung cancer 58 Renal cell carcinoma 58 benign prostatic hyperplasia enlarged 58 deCODE ProstateCancer TM 58 cervical uterine 58 benign neoplasms 58 intrahepatic bile duct 58 recurrent ovarian 58 nonmetastatic 58 metastatic GIST 58 bone marrow lymph nodes 58 pelvic malignancies 58 gynecologic malignancy 58 colorectal esophageal 58 colorectal gastric 58 ovarian uterine 58 Vicinium TM 58 squamous cell cancer 58 pancreatic adenocarcinoma 58 sorafenib tablets 58 Vandetanib 58 esophagus bladder 58 metastatic carcinoma 58 epithelial tumors 58 cirrhosis liver failure 58 metastatic androgen independent 58 prostate carcinomas 58 Basal Cell 58 recurrent metastatic 58 LHRH receptor positive 57 pancreatic cancers 57 lobular cancer 57 biliary cancer 57 bladder tumors 57 malignant neoplasm 57 epithelial cancers 57 colorectal carcinoma 57 malignant ovarian 57 osteoporosis osteoarthritis 57 hamartomas 57 metastatic adenocarcinoma 57 peritoneal carcinomatosis 57 advanced HER2 positive 57 Medullary thyroid cancer 57 nodal metastasis 57 carcinomas 57 intraductal 57 pituitary adenomas 57 papillary renal cell carcinoma 57 nonmelanoma 57 ductal cancer 57 colon ovary 57 gastric pancreatic 57 cervical carcinoma 57 neuroendocrine tumors 57 colorectal cancer CRC 57 biliary tract 57 oesophageal cancers 57 urothelial carcinoma 57 prostate cancers 57 precancerous tumors 57 metastatic bladder 57 endometrial carcinoma 57 Peritoneal mesothelioma 57 vulvar cancers 57 hematological disorders 57 solar keratosis 57 metastatic pancreatic 57 prostate testicular 57 malignancies 57 adrenocortical cancer 57 gastric cardia 57 distal colon cancer 56 Benign prostatic hyperplasia BPH 56 neuroendocrine cancers 56 adenocarcinomas 56 squamous cell 56 anal cancers 56 metastatic lymph nodes 56 brain metastases originating 56 neoplasias 56 Squamous 56 ovarian bladder 56 bile duct cancers 56 bone metastasis 56 squamous cell carcinoma SCC 56 damage cirrhosis liver 56 vaginal cancers 56 CTAP# Capsules 56 pleural mesothelioma 56 Surgical resection 56 metastatic renal 56 endometriosis ovarian cysts 56 epithelial tissues 56 tumor xenograft models 56 esophageal pancreatic 56 nasopharyngeal carcinoma 56 LungAlert TM 56 vagina cervix 56 nasopharyngeal cancer 56 uterine cancers 56 ocular melanoma 56 ovarian cancers 56 Radical prostatectomy 56 axillary lymph nodes 56 lymph nodes spleen 56 Ductal Carcinoma 56 lung carcinomas 56 Colorectal cancers 56 breast cervical 56 malignant pleural mesothelioma 56 esophageal tumors 56 prostate walnut 56 lymphoid tumors 56 HER2 positive breast 56 superficial basal cell carcinoma 56 Cholangiocarcinoma 56 esophagus stomach 56 sarcoma melanoma 56 testicular germ cell 56 faulty BRCA genes 56 endometrial kidney 56 solid tumors 56 Sezary syndrome 56 penile anal 56 lungs pancreas 55 HER2 amplified 55 Metastatic breast cancer 55 gastric adenocarcinoma 55 atypical hyperplasia 55 pancreatic islet cell 55 adhesion molecule EpCAM expressing 55 Sentinel node biopsy 55 Benign breast 55 bowel cancers 55 nonmelanoma skin cancer 55 basal cell skin 55 advanced adenomas 55 metastatic liver 55 colorectal adenoma 55 benign enlargement 55 gynecologic cancers 55 malignant neoplasms 55 relapsed leukemia 55 urogenital tract 55 Bladder cancer 55 Prostate Cancer Prostate 55 cisplatin resistant 55 advanced adenoma 55 prostate TURP 55 adenomatous 55 soft tissue sarcomas 55 myelofibrosis polycythemia vera 55 basal cell 55 lymphoma myeloma 55 hormonally sensitive 55 pulmonary metastases 55 kinase PI3K pathway 55 stage IIIb IV 55 colorectal 55 lobular breast cancer 55 sarcomatoid 55 oral deforolimus 55 leukemias lymphomas 55 polyps growths 55 HBeAg negative 55 Esophageal cancer 55 colorectal cancer 55 specific antigen PSA 55 breast carcinoma 55 gastroesophageal junction 55 aerodigestive tract 55 lung liver pancreas 55 metastatic neuroendocrine tumors 55 premalignant lesion 55 Ductal carcinoma 55 lobular carcinomas 55 histologic subtype 55 gastrointestinal stromal tumors 55 Alessandro Riva 55 colon rectal 55 Adjuvant chemotherapy 55 lungs liver pancreas 55 Oesophageal cancer 55 chemotherapy cisplatin 55 cervical anal 55 contralateral breast 55 pharynx esophagus 55 vaginal lesions 55 locoregional recurrence 55 basal cell cancer 55 HNSCC 55 cutaneous squamous cell carcinoma 55 cancerous enlargement 55 Uterine fibroids 55 Squamous cell carcinomas 55 epithelioid 55 vinca alkaloids 54 BRCA deficient 54 metastatic gastric 54 Enlarged prostate 54 unresectable liver cancer 54 Colon polyps 54 advanced metastatic prostate 54 lymphomas leukemias 54 Basal cell carcinoma 54 ductal adenocarcinoma 54 angioplasties stents 54 precancerous cervical 54 Cancer Incidence Mortality 54 non squamous NSCLC 54 Squamous Cell Carcinoma 54 esophagogastric junction 54 metastatic cancers 54 grade serous ovarian 54 ATC ovarian cancer 54 tumors GIST 54 radiation chemoradiation 54 oesophageal 54 pancreatic carcinoma 54 thyroid nodules 54 pancreas liver 54 KRAS oncogene 54 cystic fibrosis chronic pancreatitis 54 untreated metastatic pancreatic 54 recurrent NSCLC 54 chronically immunosuppressed solid 54 HER2 positive tumors 54 malignant prostate 54 Thyroid nodules 54 hematologic disorders 54 Hepatocellular carcinoma 54 precancers 54 serum prostate 54 fallopian tube cancers 54 alkylating agents 54 gene BRCA2 54 vascular disorders 54 distant metastasis 54 cervical intraepithelial neoplasia 54 FGFR2 54 endogenous estrogen 54 neoplasms 54 serous ovarian cancer 54 hormone receptor positive 54 Hepatocellular Carcinoma HCC 54 pain palliation 54 factor receptor EGFR 54 androgen dependent 54 metastatic relapsed 54 exemestane Aromasin 54 pulmonary metastasis 54 lymphoma Hodgkin lymphoma 54 genitourinary tract 54 hormone therapy estrogen 54 Rectal cancer 54 anthracycline taxane 54 hepatocellular liver 54 European Randomized Study 54 seminoma 54 advanced epithelial ovarian 54 laryngeal cancer 54 metastatic castration resistant 54 R sorafenib tablets 54 thromboembolic disease 54 malignant fibrous histiocytoma 54 systemic scleroderma 54 benign noncancerous 54 Acute myeloid leukemia 54 HER2 positive metastatic breast 54 cancerdefine 54 adenomatous polyp 54 leukemia lymphomas 54 luteinizing hormone releasing 54 oral cavity pharynx larynx 54 lymph node enlargement 54 IRX 2 54 tumor metastases 54 Hodgkin lymphoma HL 54 leiomyoma 54 novel VDA molecule 53 basal cell cancers 53 intestinal polyps 53 urologic diseases 53 hormonally responsive 53 Proxinium TM 53 cryptococcosis 53 HER2 positive breast cancer 53 parathyroid carcinoma 53 premalignant 53 grade gliomas 53 axillary dissection 53 interstitial cystitis IC 53 carcinoid tumors 53 prostate carcinoma 53 cervical lymph nodes 53 salpingo oophorectomy 53 acute myeloid 53 BCG refractory 53 Advanced Renal Cell 53 papillary 53 Squamous Cell 53 prostate adenocarcinoma 53 bone marrow suppression 53 hormone gastrin 53 lung adenocarcinomas 53 Fibroid tumors 53 pelvic lymph nodes 53 basal cell carcinomas 53 Acute lymphoblastic leukemia 53 Bone metastases 53 esophageal gastric 53 premalignant lesions 53 mouth pharynx 53 molecular abnormalities 53 vitreous floaters 53 commercialize deforolimus 53 rheumatoid arthritis systemic lupus 53 fallopian tube carcinoma 53 Chronic Lymphocytic Leukemia CLL 53 metastatic breast 53 differentiated thyroid 53 nonproliferative 53 colorectal adenocarcinoma 53 essential thrombocythemia ET 53 squamous cell skin 53 cancerous nodules 53 uterine tumors 53 postoperative pathology 53 urothelial cancer 53 Stomach cancer 53 HER2 positive cancers 53 mucinous 53 endocrine tumors 53 invasive carcinoma 53 lymphoproliferative diseases 53 obstructive jaundice 53 promoter hypermethylation 53 mesotheliomas 53 HER2 receptor 53 noncancerous tumors 53 esophageal squamous cell carcinoma 53 castrate resistant prostate cancer 53 advanced hepatocellular carcinoma 53 resistant hormone refractory 53 esophagus larynx 53 fibrocystic disease 53 antiestrogen 53 ErbB2 positive 53 eIF 4E 53 adenomatous polyps 53 grade cervical intraepithelial 53 malignant plasma 53 Metastases 53 Mitomycin C 53 hepatocellular 53 gastrointestinal stromal tumors GISTs 53 KRAS mutations occur 53 chronic thromboembolic pulmonary 53 GNAQ 53 lymphoid tissue 53 infiltrating ductal carcinoma 53 gemcitabine chemotherapy 53 Prostatitis 53 oesophageal adenocarcinoma 53 hematologic diseases 53 castrate resistant 53 removed laparoscopically 53 metastatic basal cell 53 dysplastic lesions 53 microsphere therapy 53 Metastatic colorectal cancer 53 Epithelial ovarian cancer 53 cervical vaginal 53 throat esophagus 53 kidneys lungs 53 Faslodex 53 subependymal giant cell 53 superficial bladder cancer 53 bronchogenic carcinoma 53 mucus glands 53 treating cancerous tumors 53 LRP5 53 primary peritoneal 53 Amrubicin 53 gastrointestinal malignancies 53 HER2 positive 53 breast carcinomas 53 gallstone disease 53 Evoltra ® 53 malignant melanomas 53 nonalcoholic steatohepatitis NASH 53 neovascular diseases 53 refractory metastatic 53 Acute myeloid leukemia AML 53 underarm lymph nodes 53 precancerous condition 53 prostate cancer CaP 53 Hurthle cell 53 GSTP1 53 grade cervical dysplasia 53 Osteoporosis affects 53 advanced unresectable 53 AML MDS 53 Malignant Melanoma 53 lung cancer asbestosis 53 depsipeptide 53 Carcinoma 53 kidney liver pancreas 53 fibroadenomas 52 histological subtypes 52 HER2 ErbB2 52 stomach duodenum 52 detect precancerous lesions 52 situ DCIS 52 squamous cell lung cancer 52 basal cell nevus syndrome 52 Adenomas 52 Vidaza ® 52 noncancerous growths 52 common hematologic malignancy 52 situ LCIS 52 VEGF receptors 52 carcinoid 52 primary hyperparathyroidism 52 radiosensitive 52 prognostic indicator 52 deCODE BreastCancer TM 52 JNK pathway 52 Bayer Nexavar 52 cutaneous melanoma 52 advanced metastatic renal 52 lenalidomide Revlimid R 52 ZACTIMA TM ZD# 52 Human papillomavirus HPV 52 spinal metastases 52 hematological diseases 52 lung cancer NSCLC 52 HER2 positivity 52 malignant growths 52 TRAIL R1 52 tumor metastasis 52 Endometrial 52 Benign Prostatic Hypertrophy 52 CDH1 52 breast prostate 52 cytoreduction 52 underwent prostatectomy 52 p# mutations 52 emphysema chronic bronchitis 52 docetaxel Taxotere ® 52 benign nodules 52 carcinoma 52 thyroid carcinomas 52 demonstrated antitumor activity 52 HER2 neu 52 esthesioneuroblastoma rare form 52 Renal impairment 52 gastrointestinal stromal tumor 52 ANCA associated 52 lymph node removal 52 Hepatocellular carcinoma HCC 52 urothelial 52 Aortic stenosis 52 pharynx larynx 52 gastric carcinoma 52 mesothelium 52 neurofibromas 52 ADPKD 52 invasive ductal carcinoma 52 peritoneal cancer 52 clinically localized prostate 52 Shark cartilage 52 invasive ductal carcinomas 52 Malignant mesothelioma 52 GISTs 52 follicular thyroid cancer 52 Glioblastomas 52 molecular subtypes 52 radiofrequency ablation RFA 52 AAT Deficiency 52 Anaplastic 52 chemo resistant 52 bacteremic pneumonia 52 squamous 52 leukemia myeloma 52 palliative radiotherapy 52 neoadjuvant therapy 52 lymphoid malignancies 52 lung cancers 52 hypervascular 52 hormone refractory metastatic prostate 52 underwent radical prostatectomy 52 Study Tanning beds 52 PCA3 scores 52 circulating rotavirus 52 colon cancers 52 Meningiomas 52 dysplastic nevi 52 urologic cancers 52 Chronic lymphocytic leukemia 52 atrophic gastritis 52 macrovascular complications 52 human papillomaviruses HPV 52 operable breast cancer 52 secondary hyperparathyroidism 52 chronic myeloid 52 Nexavar tablets 52 Glioblastoma multiforme GBM 52 uterus fallopian tubes 52 Systemic lupus erythematosus 52 castration resistant 52 pAkt 52 HRPC 52 symptomatic fibroids 52 colorectal adenomas 52 Adenocarcinoma 52 metastatic castrate resistant 52 Invasive Breast Cancer 52 melanoma basal cell 52 gynecologic cancer 52 transitional cell carcinoma 52 malignant polyps 52 Menopausal hormone therapy 52 dysglycemia 52 Pleural mesothelioma 52 radioiodine therapy 52 colorectal polyp 52 histologic subtypes 52 pancreatic neuroendocrine 52 leiomyosarcoma 52 cerebrovascular diseases 52 gastrointestinal stromal tumor GIST 52 keloid scarring treatment 52 papillomas 52 RSV infects 52 recurrent prostate cancer 52 Folfox 52 Sudhir Agrawal D.Phil 52 Epstein Barr virus EBV 52 commonest cancers 52 lymph node biopsies 52 axillary lymph node dissection 52 malignant cancerous 52 progesterone receptor negative 52 cetuximab Erbitux 52 malignant pancreatic 52 HGPIN 52 radiochemotherapy 52 testicular tumors 52 androgenetic alopecia 52 Nephrogenic Systemic Fibrosis NSF 52 colon rectal cancer 52 familial amyloidotic polyneuropathy FAP 52 immunological diseases 52 BRCA1 BRCA2 52 sentinel nodes 52 Modrenal 52 transplantation HCT 52 hyperplastic 52 pediatric malignancies 52 cancer mCRC 52 cervical lesions 52 androgenic hormones 52 myeloproliferative neoplasms 51 Renal Cell Carcinoma RCC 51 IGF IR 51 commercializes oncology 51 pre cancerous growths 51 commonly mutated genes 51 rectal cancer 51 Osteoarthritis OA 51 gynecological cancer 51 Malignant melanoma 51 gynecological cancers 51 transfusion syndrome 51 prostate cancer HRPC 51 atypical ductal hyperplasia 51 Hormonal therapy 51 Pancreatic neuroendocrine tumors 51 chronic prostatitis 51 ACE inhibitors dilate 51 Glioblastoma multiforme 51 malignant brain 51 pan HDAC inhibitor 51 astrocytomas 51 sodium thiosulfate STS 51 cervix anus 51 Kit CD# positive 51 lobular 51 metastatic colon cancer 51 sickle cell cystic fibrosis 51 keratoses 51 medically inoperable 51 lung resections 51 CHD CVD 51 trastuzumab DM1 51 hamartoma 51 ductal lavage 51 bone metastases 51 CIN2 + 51 oral squamous cell 51 cirrhosis liver cancer 51 larynx esophagus 51 Herceptin trastuzumab 51 cardio vascular disease 51 eflornithine 51 sorafenib Nexavar 51 hepatocellular cancer 51 carcinoids 51 anal lesions 51 YONDELIS 51 malignant pleural mesothelioma MPM 51 metastatic lung cancer 51 pre cancerous lesions 51 benign growths 51 Basal cell carcinomas 51 Ribavirin causes 51 pancreatic endocrine 51 Hormone pills 51 faulty BRCA2 gene 51 desmoplastic 51 precancerous cervical lesions 51 pancreas gland 51 node metastases 51 Glioma 51 distant metastases 51 prostate cancer PCa 51 squamous cell carcinoma 51 preclinical xenograft models 51 cervical cancers 51 lymphatic tissue 51 vascular occlusive diseases 51 sPLA2 51 papilloma 51 pharyngeal cancer 51 FOLFOX6 51 uterus womb 51 carcinoembryonic antigen 51 neoplastic lesions 51 metastases 51 M2 subunit 51 mutated BRCA1 51 Implantable cardioverter defibrillators ICDs 51 non resectable 51 proximal colon 51 leukaemias 51 patients undergoing chemotherapy 51 metastatic lesions 51 adipose fat 51 hormonal therapies 51 osteoporotic fractures 51 VEGFR2 inhibitor 51 schwannomas 51 SHPT 51 colorectal tumors 51 CMV disease 51 Atopic eczema 51 colorectal neoplasms 51 paragangliomas 51 metastatic HER2 negative 51 investigational monoclonal antibody 51 MALT lymphoma 51 unresectable locally advanced 51 gastric cancer 51 TTR gene 51 benign prostatic hypertrophy 51 Gliomas 51 cytotoxic therapy 51 antigen PSA 51 adenoma 51 Fludara ® 51 pancreatic NET 51 hepatocellular carcinoma HCC 51 alkylating agent 51 thymectomy 51 letrozole Femara 51 endostatin 51 cervical dysplasia 51 bilateral oophorectomy 51 gastrointestinal perforation 51 orchiectomy 51 renal carcinoma 51 obese postmenopausal 51 EGFR HER2 51 ALK inhibitor 51 goserelin 51 bone spurs bulging 51 kidney fibrosis 51 Benign Prostatic Hyperplasia BPH 51 recurrent ovarian cancer 51 nutlin 3a 51 chronic periodontitis 51 excessive menstrual bleeding 51 spinal stenosis degenerative disc 51 Malignant gliomas 51 chemotherapeutic regimens 51 intravenous bisphosphonates 51 hypoxia inducible factor 51 cell carcinomas 51 Pemetrexed 51 GSTT1 51 benign uterine 51 Glioblastoma Multiforme GBM 51 metastic 51 paclitaxel Taxol 51 diagnosed glioblastoma multiforme 51 parotid salivary gland 51 5 Fluorouracil 51 renal cell carcinoma 51 inherited mutations 51 ipsilateral breast 51 #.#ng/ml 51 FSGS affects 51 ductal lobular 51 intestinal metaplasia 51 undescended testes 51 relapsed ovarian cancer 51 Relapsing remitting MS 51 haematopoietic 51 abdomen pelvis 51 gastrointestinal tract diverticulitis gastrointestSteven Fromholz 51 ELOXATIN 51 androgen receptor antagonist 51 spine fractures 50 tumor subtypes 50 evaluating T DM1 50 choriocarcinoma 50 gynecological malignancies 50 anti angiogenic therapy 50 Leydig cell 50 diffuse gastric 50 carcinoid tumor 50 severe degenerative ischemic 50 dermatofibrosarcoma protuberans 50 hepatocellular carcinoma 50 mycosis fungoides 50 Colorectal cancer 50 uveal melanoma 50 invasive bladder 50 medullary thyroid cancer 50 biliary tract cancer 50 chondrosarcoma 50 medulloblastoma malignant brain tumor 50 c MYC 50 colonic polyps 50 Salvatore Glorioso mayor 50 rosacea acne 50 pre cancerous actinic 50 K ras mutations 50 preoperative chemotherapy 50 microcirculatory improvement helping 50 cirrhosis scarring 50 polycystic ovarian syndrome PCOS 50 Vascular dementia 50 colon tumors 50 AEG# 50 severe oral mucositis 50 malignant ascites 50 trans retinoic acid 50 EGFR mutation 50 atypical moles 50 exocrine glands 50 BRCA1 mutation carriers 50 HER2 overexpression 50 PI3K/Akt pathway inhibitor 50 muscular dystrophy cystic fibrosis 50 glomerulonephritis 50 dysentery bursitis 50 external genital lesions 50 Candida infection 50 androgen independent 50 ocular disorders 50 psoriasis Crohn disease 50 Radiation therapy 50 histological subtype 50 Diabetic nephropathy 50 tubulin inhibitor 50 male hormones androgens 50 benign breast 50 biliary stones 50 systemic autoimmune 50 phytoestrogen 50 lymphatic cancers 50 arterial calcification 50 hemoglobinopathies 50 alpha folate receptor 50 LHRH analogues 50 ovarian carcinoma 50 IgG1 monoclonal antibody 50 malignant lesions 50 pre cancerous polyps 50 Vidofludimus 50 CP CPPS 50 Philadelphia Chromosome Positive 50 adrenal cortex 50 pre cancerous lesion 50 metastatic cancer 50 endometrial tumors 50 Degarelix 50 TNF blocker therapy 50 serine proteases 50 genes BRCA1 50 Folate deficiency 50 lung metastases 50 laryngeal cancers 50 polycystic ovary syndrome PCOS 50 urothelial bladder cancer 50 cervical lymph node 50 ixabepilone 50 resectable 50 treat musculoskeletal metabolic 50 Chlamydia infection 50 Phase #/#a trial 50 parathyroid 50 pT2 50 Human papillomavirus 50 B7 H3 50 armpit lymph nodes 50 Selective Internal 50 gefitinib Iressa 50 pleomorphic 50 Multiple myeloma 50 kidneys pancreas 50 platinum refractory 50 ZACTIMA 50 GnRH agonists 50 androgen receptor AR 50 gastrointestinal stromal tumors GIST 50 advanced carcinoid 50 polyp recurrence 50 metastatic ovarian cancer 50 angiosarcoma 50 multi kinase inhibitor 50 bevacizumab Avastin ® 50 colorectal polyps 50 ALA PDT 50 Nexavar sorafenib 50 hormone deprivation 50 node metastasis 50 pheochromocytoma 50 Photodynamic Therapy PDT 50 trans retinoic acid ATRA 50 NMIBC 50 cardiovascular restenosis cancer 50 antibody MAb 50 tendon dislocated shoulder 50 AA Amyloidosis 50 localized renal 50 Cojocaru correspondent 50 Elotuzumab 50 endometrial 50 colorectal carcinomas 50 beta carotene supplementation 50 hereditary predisposition 50 lung pancreas 50 hemorrhage necrosis 50 diseases osteoarthritis osteoporosis 50 lymphoma subtypes 50 SPINK1 50 lobules 50 liver resection 50 Medulloblastoma 50 Neulasta ® 50 metastatic carcinoid 50 Systemic lupus 50 cervical precancers 50 relapsed acute lymphoblastic 50 Chronic myeloid leukemia 50 orally administered inhibitor 50 cediranib 50 Melanomas 50 Oestrogen 50 mutated K ras 50 recurrent glioblastoma multiforme 50 Prostate Lung Colorectal 50 Taxotere docetaxel 50 renal tumors 50 chronic eosinophilic leukemia 50 tuberous sclerosis TS 50 Radiofrequency ablation 50 histologies